Parkman Healthcare Partners LLC Entera Bio Ltd. Transaction History
Parkman Healthcare Partners LLC
- $687 Million
- Q4 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 413,732 shares of ENTX stock, worth $959,858. This represents 0.13% of its overall portfolio holdings.
Number of Shares
413,732
Previous 411,076
0.65%
Holding current value
$959,858
Previous $781,000
10.12%
% of portfolio
0.13%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding ENTX
# of Institutions
18Shares Held
7.52MCall Options Held
24.5KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$13.6 Million7.89% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY632KShares$1.47 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL212KShares$492,9600.0% of portfolio
-
Perigon Wealth Management, LLC San Francisco, CA146KShares$338,3550.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny61.8KShares$143,3760.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $66.8M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...